{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:12:36Z","timestamp":1740107556849,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>The recent availability of vaccines against COVID-19 has sparked national and international debate on the feasibility of administering them to pregnant and lactating women, given that these vaccines have not been tested to assess their safety and efficacy in such women. As concerns the risks of COVID-induced disease, published data show that pregnant women who develop COVID-19 have fewer symptoms than patients who are not pregnant, but they are more likely to need hospitalization in intensive care, and neonatal morbidity. Aim of the present perspective paper is to analyze the current literature regarding the use of the vaccine against COVID-19 infection, in terms of safety and protection, in high risk pregnant women as those affected by diabetes and obesity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Analysis of literature about vaccination against COVID-19 infection in pregnancy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The main health organizations and international scientific societies, emphasize that\u2014although data regarding the use of COVID vaccines during pregnancy and lactation are still lacking\u2014vaccination should not be contraindicated. It should be considered for pregnant women at high risk of exposure to COVID-19. For such women, the potential benefits and risks should be assessed by the healthcare professionals caring for them. A recent prospective study to test the immunogenicity and reactogenicity of vaccination with COVID-19 mRNA in pregnant and lactating women, has showed that SARS-CoV-2 mRNA vaccination triggers a robust humoral immunity in pregnant and lactating women; there was also evidence of an immune transfer to their newborn.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We urgently need data on the effect of COVID-19 vaccination, in terms of maternal and fetal outcomes and vaccine related symptoms in high risk women during pregnancy and breastfeeding. It is important to run campaigns to promote vaccination, in particular in pregnant women at high risk to have severe COVID infection as those diabetics and\/or obese.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00592-021-01764-0","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T04:02:38Z","timestamp":1624852958000},"page":"1581-1585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vaccination against COVID-19 infection: the need of evidence for diabetic and obese pregnant women"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9207-7704","authenticated-orcid":false,"given":"A.","family":"Lapolla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Dalfr\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"1764_CR1","unstructured":"European Medicines Agency. Cominarty.21 December 2020"},{"key":"1764_CR2","unstructured":"European Medicines Agency. COVID-19 Vaccine Moderna. 06 January 2021"},{"key":"1764_CR3","doi-asserted-by":"publisher","first-page":"m3320","DOI":"10.1136\/bmj.m3320","volume":"370","author":"J Allotey","year":"2020","unstructured":"Allotey J, Stallings E, Bonet M et al (2020) Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 370:m3320. https:\/\/doi.org\/10.1136\/bmj.m3320","journal-title":"BMJ"},{"issue":"3","key":"1764_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4415\/ANN_20_03_17","volume":"56","author":"A Maraschini","year":"2020","unstructured":"ItOSS COVID-19 Working Group, Maraschini A, Corsi E, Salvatore MA et al (2020) Coronavirus and birth in Italy: results of a national population-based cohort study. Ann Ist Super Sanita Jul-Sep 56(3):378\u2013389. https:\/\/doi.org\/10.4415\/ANN_20_03_17","journal-title":"Ann Ist Super Sanita Jul-Sep"},{"issue":"44","key":"1764_CR5","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","volume":"69","author":"LD Zambrano","year":"2020","unstructured":"CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, Zambrano LD, Ellington S, Strid P et al (2020) Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status, United States. MMWR Morb Mortal Wkly Rep. 69(44):1641\u20131647. https:\/\/doi.org\/10.15585\/mmwr.mm6944e3","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"1764_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100446","author":"A Khalil","year":"2020","unstructured":"Khalil A, Kalafat E, Benlioglu C et al (2020) SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100446","journal-title":"EClinicalMedicine"},{"issue":"38","key":"1764_CR7","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.15585\/mmwr.mm6938e2","volume":"69","author":"L Panagiotakopoulos","year":"2020","unstructured":"Panagiotakopoulos L, Myers TR, Gee J et al (2020) SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics: eight U.S. Health Care Centers, March 1-May 30, 2020. MMWR Morb Mortal Wkly Rep. 69(38):1355\u20131359. https:\/\/doi.org\/10.15585\/mmwr.mm6938e2","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"1764_CR8","unstructured":"CDC (2020) COVID data Tracker. Published March 28, 2020. https:\/\/www.77covid.cdc.gov\/covid-data-tracker\/"},{"issue":"2","key":"1764_CR9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/ijerph18020596","volume":"18","author":"M Papapanou","year":"2021","unstructured":"Papapanou M, Papaioannou M, Petta A et al (2021) Maternal and neonatal characteristics and outcomes of COVID-19 in pregnancy: an overview of systematic reviews. Int J Environ Res Public Health. 18(2):596. https:\/\/doi.org\/10.3390\/ijerph18020596","journal-title":"Int J Environ Res Public Health."},{"key":"1764_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejogrb.2020.11.038","volume":"256","author":"I Bellos","year":"2021","unstructured":"Bellos I, Pandita A, Panza R (2021) Maternal and perinatal outcomes in pregnant women infected by SARS-CoV-2: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 256:194\u2013204. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.11.038","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"1764_CR11","unstructured":"Centers for Disease Control and Prevention. Vaccine safety monitoring-VSD safety data link: https:\/\/www.cdc.gov\/vaccinessafety\/ensuringsafety\/m"},{"key":"1764_CR12","unstructured":"WHO (2021) Interim recommendations for the use of the moderna m-RNA-1273 vaccine against COVIS-19. Interim guidance 26 January 2021"},{"key":"1764_CR13","unstructured":"FDA New Release (2020) FDA taskes key action in fight against COVID-19 issuing emergency use authorization for first COVID-19 vaccine. December 11, 2020"},{"key":"1764_CR14","unstructured":"American College of Obstetricians and Gynecologists (ACOG). Vaccinating pregnant and lactating patients against COVID-19. December 13, 2020"},{"key":"1764_CR15","unstructured":"Royal College of Obstetricians & Gynaecologists (RCOG). Update advice on COVID-19 vaccination in pregnancy and women who are brestfeeding. News 30 Dicember 2020"},{"key":"1764_CR16","unstructured":"European Medicines Agency (EMA) COVID-19 vaccine Moderna. 06 January 2021. Covid -19 Vaccine Astra Zeneca. 29 January 2021"},{"key":"1764_CR17","unstructured":"Italian Obstetric Surveillance System (ItOSS). The use of COVID-19 vaccines in pregnant and lactating patients.January 31, 2021"},{"key":"1764_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104983","author":"TT Shimabukuro","year":"2021","unstructured":"CDC v-safe COVID-19 Pregnancy Registry Team, Shimabukuro TT, Kim SY, Myers TR et al (2021) Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2104983","journal-title":"N Engl J Med"},{"key":"1764_CR19","first-page":"e210038","volume":"29","author":"DD Flannery","year":"2021","unstructured":"Flannery DD, Gouma S, Dhudasia MB et al (2021) Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios. JAMA Pediatr 29:e210038","journal-title":"JAMA Pediatr"},{"key":"1764_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.03.023","author":"KJ Gray","year":"2012","unstructured":"Gray KJ, Bordt EA, Atyeo C et al (2012) COVID19 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol Mar. https:\/\/doi.org\/10.1016\/j.ajog.2021.03.023","journal-title":"Am J Obstet Gynecol Mar"},{"issue":"7","key":"1764_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1464-5491.2011.03541.x","volume":"29","author":"BS Buckley","year":"2012","unstructured":"DALI Core Investigator Group, Buckley BS, Harreiter J, Damm P et al (2012) Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening\u2014a review. Diabet Med. 29(7):844\u201354. https:\/\/doi.org\/10.1111\/j.1464-5491.2011.03541.x","journal-title":"Diabet Med."},{"key":"1764_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.diabres.2017.03.030","volume":"129","author":"CE Eades","year":"2017","unstructured":"Eades CE, Cameron DM, Evans JMM (2017) Prevalence of gestational diabetes mellitus in Europe: a meta-analysis. Diab Res Clin Pract. 129:173\u2013181. https:\/\/doi.org\/10.1016\/j.diabres.2017.03.030","journal-title":"Diab Res Clin Pract."},{"key":"1764_CR23","doi-asserted-by":"crossref","unstructured":"Intire MHD, Dekker M, Barrett HL et al. (2020) Obesity in pregnancy. Epidemiology, mechanisms, nutritional and metabolic management. In: PM Karger (ed.), Gestational diabetes: a decade after the HAPO study. RDS A Lapolla, B Metzger. Frontiers in Diabetes. pp 21\u201334","DOI":"10.1159\/000480163"},{"key":"1764_CR24","doi-asserted-by":"publisher","first-page":"602477","DOI":"10.3389\/fendo.2020.602477","volume":"11","author":"MG Dalfr\u00e0","year":"2020","unstructured":"Dalfr\u00e0 MG, Burlina S, Del Vescovo GG et al (2020) Genetics and epigenetics: new insight on gestational diabetes mellitus. Front Endocrinol. 11:602477. https:\/\/doi.org\/10.3389\/fendo.2020.602477","journal-title":"Front Endocrinol."},{"issue":"12","key":"1764_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/bdr2.1696","volume":"112","author":"JM Graham Jr","year":"2020","unstructured":"Graham JM Jr (2020) Update on the gestational effects of maternal hyperthermia. Birth Defects Res 112(12):943\u2013952. https:\/\/doi.org\/10.1002\/bdr2.1696","journal-title":"Birth Defects Res"},{"issue":"10","key":"1764_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.it.2018.08.008","volume":"39","author":"AI Wells","year":"2018","unstructured":"Wells AI, Coyne CB (2018) Type III interferons in antiviral defenses at barrier surfaces. Trends Immunol 39(10):848\u2013858. https:\/\/doi.org\/10.1016\/j.it.2018.08.008","journal-title":"Trends Immunol"},{"issue":"19","key":"1764_CR27","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1128\/JVI.00985-20","volume":"94","author":"A Vanderheiden","year":"2020","unstructured":"Vanderheiden A, Ralfs P, Chirkova T et al (2020) Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J Virol 94(19):e00985-e1020. https:\/\/doi.org\/10.1128\/JVI.00985-20","journal-title":"J Virol"},{"issue":"1","key":"1764_CR28","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1038\/s41467-020-17436-6","volume":"11","author":"AJ Vivanti","year":"2020","unstructured":"Vivanti AJ, Vauloup-Fellous C, Prevot S et al (2020) Transplacental transmission of SARS-CoV-2 infection. Nat Commun 11(1):3572","journal-title":"Nat Commun"},{"issue":"9","key":"1764_CR29","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1172\/JCI139569.","volume":"130","author":"H Hosier","year":"2020","unstructured":"Hosier H, Farhadian SF, Morotti RA et al (2020) SARS-CoV-2 infection of the placenta. J Clin Inv 130(9):4947\u20134953. https:\/\/doi.org\/10.1172\/JCI139569.","journal-title":"J Clin Inv"},{"issue":"5","key":"1764_CR30","doi-asserted-by":"publisher","first-page":"e13306","DOI":"10.1111\/aji.13306","volume":"84","author":"E Prochaska","year":"2020","unstructured":"Prochaska E, Jang M, Burd I (2020) COVID-19 in pregnancy: placental and neonatal involvement. Am J Reprod Immunol. 84(5):e13306. https:\/\/doi.org\/10.1111\/aji.13306","journal-title":"Am J Reprod Immunol."},{"issue":"1","key":"1764_CR31","doi-asserted-by":"publisher","first-page":"e03192","DOI":"10.1128\/mBio.03192-20","volume":"12","author":"RM Pace","year":"2021","unstructured":"Pace RM, Williams JE, J\u00e4rvinen KM et al (2021) Characterization of SARS-CoV-2 RNA, Antibodies, and neutralizing capacity in milk produced by women with COVID-19. mbio 12(1):e03192-20. https:\/\/doi.org\/10.1128\/mBio.03192-20","journal-title":"mbio"},{"issue":"18","key":"1764_CR32","doi-asserted-by":"publisher","first-page":"9555","DOI":"10.1128\/JVI.05174-11","volume":"85","author":"GG Fouda","year":"2011","unstructured":"Center for HIV\/AIDS Vaccine Immunology, Fouda GG, Yates NL, Pollara J et al (2011) HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies. J Virol. 85(18):9555\u201367. https:\/\/doi.org\/10.1128\/JVI.05174-11","journal-title":"J Virol."},{"issue":"2","key":"1764_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10654-021-00728-6","volume":"36","author":"M Skjefte","year":"2021","unstructured":"Skjefte M, Ngirbabul M, Akeju O et al (2021) COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol 36(2):197\u2013211. https:\/\/doi.org\/10.1007\/s10654-021-00728-6","journal-title":"Eur J Epidemiol"},{"key":"1764_CR34","doi-asserted-by":"publisher","first-page":"100352","DOI":"10.1016\/j.ajogmf.2021.100352","volume":"23","author":"L Carbone","year":"2021","unstructured":"Carbone L, Mappa I, Sirico A et al (2021) Pregnant women perspectives on SARS-COV-2 vaccine: condensation: most of Italian pregnant women would not agree to get the SARS-COV-2 vaccine, irrespective of having features of high risk themselves, or being high-risk pregnancies. Am J Obstet Gynecol MFM 23:100352. https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100352","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"1","key":"1764_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1089\/bfm.2020.29172.abm","volume":"16","author":"A Stuebe","year":"2021","unstructured":"Stuebe A (2021) Considerations for COVID-19 Vaccination in Lactation. Breastfeed Med 16(1):2. https:\/\/doi.org\/10.1089\/bfm.2020.29172.abm","journal-title":"Breastfeed Med"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-021-01764-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T14:04:28Z","timestamp":1635084268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-021-01764-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1764"],"URL":"https:\/\/doi.org\/10.1007\/s00592-021-01764-0","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"type":"print","value":"0940-5429"},{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}